Javier Sánchez Doncell, Carina A Sotelo, Sandra E Menéndez, Ignacio Braga, Sergio Giamperetti, José L Francos
Introduction: Dengue is a disease transmitted by mosquitoes of the Aedes genus; this has presented a historical increase in cases in South America, which represents a public health problem. From the Febrile Emergency Unit (UFU) of Hospital Muñiz, the laboratory results were analyzed and the circulating serotype was identified at the level of the Autonomous City of Buenos Aires (CABA), confirming the proportion of indigenous cases, recording symptoms and epidemiology. The objective of this analysis is to highlight the increase in indigenous cases of dengue in CABA.
Methods: An observational and retrospective study was carried out, from January 1 to May 8, 2023, of the positive PCR results for dengue.
Results: 1159 patients with febrile symptoms were assisted, of which 554 (47.7%) were probable cases while the remaining 542 (46.7%) were febrile syndromes of another etiology. Of the probable cases, 162 with positive PCR results (29%) were evaluated, of which 18 (11%) were imported and 144 (89%) native. DENV-2 predominated (86% of confirmed cases). The clinical manifestations were fever (100%), myalgia (100%), headache (98%), arthralgia (87%), nausea (46%), and retroocular pain (39%).
Discussion: For 10 years, there has been an increase in the number of indigenous dengue cases in CABA. In the analysis of this article, autochthonous dengue appears as an outbreak at the city level. Notification of the clinic and epidemiology is important to consider public health strategies in the fight against dengue and possible new studies related to outbreaks and epidemics.
{"title":"[Analysis of indigenous dengue in an infectious diseases Hospital in Buenos Aires, Argentina].","authors":"Javier Sánchez Doncell, Carina A Sotelo, Sandra E Menéndez, Ignacio Braga, Sergio Giamperetti, José L Francos","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Dengue is a disease transmitted by mosquitoes of the Aedes genus; this has presented a historical increase in cases in South America, which represents a public health problem. From the Febrile Emergency Unit (UFU) of Hospital Muñiz, the laboratory results were analyzed and the circulating serotype was identified at the level of the Autonomous City of Buenos Aires (CABA), confirming the proportion of indigenous cases, recording symptoms and epidemiology. The objective of this analysis is to highlight the increase in indigenous cases of dengue in CABA.</p><p><strong>Methods: </strong>An observational and retrospective study was carried out, from January 1 to May 8, 2023, of the positive PCR results for dengue.</p><p><strong>Results: </strong>1159 patients with febrile symptoms were assisted, of which 554 (47.7%) were probable cases while the remaining 542 (46.7%) were febrile syndromes of another etiology. Of the probable cases, 162 with positive PCR results (29%) were evaluated, of which 18 (11%) were imported and 144 (89%) native. DENV-2 predominated (86% of confirmed cases). The clinical manifestations were fever (100%), myalgia (100%), headache (98%), arthralgia (87%), nausea (46%), and retroocular pain (39%).</p><p><strong>Discussion: </strong>For 10 years, there has been an increase in the number of indigenous dengue cases in CABA. In the analysis of this article, autochthonous dengue appears as an outbreak at the city level. Notification of the clinic and epidemiology is important to consider public health strategies in the fight against dengue and possible new studies related to outbreaks and epidemics.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 1","pages":"81-86"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139564345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cecilia Bianchi, Romina P Martinelli, Viviana R Rozados, O Graciela Scharovsky
In recent years, drug repurposing (DR) has gained significant attention as a promising strategy for identifying new therapeutic uses of existing drugs. One potential candidate for DR in cancer treatment is sodium dichloroacetate (DCA), which has been shown to alter tumor metabolism and decrease apoptosis resistance in cancer cells. In this paper, we present a scoping review of the use of DCA for cancer treatment in adult patients, aiming to identify key research gaps in this area. This scoping review aims to explore the existing scientific literature to provide an overview of the use of DCA (any dose, frequency, or route of administration) in adults with cancer. A comprehensive literature search of the medical databases MEDLINE/PubMed, LILACS, EPISTEMONIKOS, the Cochrane Library, and ClinicalTrials was performed. We included publications reporting on adult patients diagnosed with any type of cancer treated with sodium dichloroacetate in combination or not with other drugs. All types of study design were included. A total of 12 articles were included, most of them were case reports. We found a high degree of heterogeneity between them. The most frequent adverse events in the evaluated studies were asthenia, reversible toxicity, and an increase in liver enzymes. Effectiveness was difficult to evaluate. We conclude that there is insufficient evidence to affirm that treatment with DCA in cancer patients is effective or is safe.
{"title":"Use of sodium dichloroacetate for cancer treatment: a scoping review.","authors":"Cecilia Bianchi, Romina P Martinelli, Viviana R Rozados, O Graciela Scharovsky","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In recent years, drug repurposing (DR) has gained significant attention as a promising strategy for identifying new therapeutic uses of existing drugs. One potential candidate for DR in cancer treatment is sodium dichloroacetate (DCA), which has been shown to alter tumor metabolism and decrease apoptosis resistance in cancer cells. In this paper, we present a scoping review of the use of DCA for cancer treatment in adult patients, aiming to identify key research gaps in this area. This scoping review aims to explore the existing scientific literature to provide an overview of the use of DCA (any dose, frequency, or route of administration) in adults with cancer. A comprehensive literature search of the medical databases MEDLINE/PubMed, LILACS, EPISTEMONIKOS, the Cochrane Library, and ClinicalTrials was performed. We included publications reporting on adult patients diagnosed with any type of cancer treated with sodium dichloroacetate in combination or not with other drugs. All types of study design were included. A total of 12 articles were included, most of them were case reports. We found a high degree of heterogeneity between them. The most frequent adverse events in the evaluated studies were asthenia, reversible toxicity, and an increase in liver enzymes. Effectiveness was difficult to evaluate. We conclude that there is insufficient evidence to affirm that treatment with DCA in cancer patients is effective or is safe.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 2","pages":"313-323"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Fajreldines, Antonela Pauluzzi, Silvio Torres, Marcelo Pellizzari
Introduction: Prescription is the node of medication management and use that most frequently presents medication errors, according to various studies. This study aims to analyze prescriptions before and after the incorporation of a multidisciplinary round in the pediatric intensive care area and its implication in the occurrence of adverse drug events.
Methods: This is an uncontrolled before and after study.
Results: 100 patients were studied before and 100 after, range 1-17 years, mean age: 6.4 SD: 8.7. 55.5% (n = 111) were men. A prescription error was detected before the intervention of 12% (n = 12) and after 0% of the intervention, 0%, p = 0.001. A total of 45 adverse events were detected, that is, 45 adverse events per 100 admissions and 38, that is, 38 events per 100 admissions, before and after the intervention respectively (p > 0.05).
Conclusion: The intervention was useful to reduce prescription error in this sample of patients.
{"title":"[Reduction of prescription error and its adverse effects in the pediatric intensive care area].","authors":"Ana Fajreldines, Antonela Pauluzzi, Silvio Torres, Marcelo Pellizzari","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Prescription is the node of medication management and use that most frequently presents medication errors, according to various studies. This study aims to analyze prescriptions before and after the incorporation of a multidisciplinary round in the pediatric intensive care area and its implication in the occurrence of adverse drug events.</p><p><strong>Methods: </strong>This is an uncontrolled before and after study.</p><p><strong>Results: </strong>100 patients were studied before and 100 after, range 1-17 years, mean age: 6.4 SD: 8.7. 55.5% (n = 111) were men. A prescription error was detected before the intervention of 12% (n = 12) and after 0% of the intervention, 0%, p = 0.001. A total of 45 adverse events were detected, that is, 45 adverse events per 100 admissions and 38, that is, 38 events per 100 admissions, before and after the intervention respectively (p > 0.05).</p><p><strong>Conclusion: </strong>The intervention was useful to reduce prescription error in this sample of patients.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 3","pages":"426-432"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141440617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladimir Becerra-Canales, Medalith Campos-Sobrino, Morayma Campos-Sobrino, Ricardo D Martinez-Muñante
Introduction: Visual inspection with acetic acid (VIA) is a primary alternative to reduce cervical cancer (CaCu) incidence and mortality. The study aimed to determine the proportion of women aged 30-49 years who used VIA in the last two years and the factors associated with the use of the test in the primary care setting.
Methods: Cross-sectional, multicenter study. Seven hundred and six women aged 30 to 49 years participated, users of primary health care centers in a region of Peru. The dependent variable was the use of the VIA test in the last two years and the independent variables were sociodemographic, socio-health, information and attitudinal factors.
Results: The proportion of women who used the VIA test was 30.6%. The following factors were associated with greater use of the test: urban area of residence, having received a recommendation for VIA, feeling worried about acquiring CaCu, having heard about CaCu and the human papilloma virus. Also, considering having a greater or equal probability of developing CaCu compared to women of the same age, and with lower use of the test, coming from the highlands and considering it risky to undergo VIA.
Conclusion: The VIA screening program for CaCu would not be achieving the desired impact. There is a need to strengthen strategies and interventions in primary care to improve screening behaviors and rates.
导言:醋酸目视检查(VIA)是降低宫颈癌(CaCu)发病率和死亡率的主要替代方法。该研究旨在确定 30-49 岁女性在过去两年中使用 VIA 的比例,以及在初级保健环境中使用该检测的相关因素:方法:横断面多中心研究。秘鲁某地区初级医疗中心的 760 名 30-49 岁妇女参加了此次研究。因变量为过去两年中使用 VIA 检测的情况,自变量为社会人口、社会健康、信息和态度等因素:使用 VIA 检测的妇女比例为 30.6%。以下因素与更多人使用该检测有关:居住在城市地区、收到过 VIA 建议、担心感染 CaCu、听说过 CaCu 和人类乳头瘤病毒。此外,与同龄妇女相比,认为自己患 CaCu 的可能性更大或相等的妇女,使用检测的比例较低的妇女,来自高原地区的妇女,认为进行 VIA 有风险的妇女:结论:针对 CaCu 的 VIA 筛查计划无法达到预期效果。有必要加强初级保健的战略和干预措施,以改善筛查行为并提高筛查率。
{"title":"[Visual inspection with acetic acid and the control of cervical cancer in primary care].","authors":"Bladimir Becerra-Canales, Medalith Campos-Sobrino, Morayma Campos-Sobrino, Ricardo D Martinez-Muñante","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Visual inspection with acetic acid (VIA) is a primary alternative to reduce cervical cancer (CaCu) incidence and mortality. The study aimed to determine the proportion of women aged 30-49 years who used VIA in the last two years and the factors associated with the use of the test in the primary care setting.</p><p><strong>Methods: </strong>Cross-sectional, multicenter study. Seven hundred and six women aged 30 to 49 years participated, users of primary health care centers in a region of Peru. The dependent variable was the use of the VIA test in the last two years and the independent variables were sociodemographic, socio-health, information and attitudinal factors.</p><p><strong>Results: </strong>The proportion of women who used the VIA test was 30.6%. The following factors were associated with greater use of the test: urban area of residence, having received a recommendation for VIA, feeling worried about acquiring CaCu, having heard about CaCu and the human papilloma virus. Also, considering having a greater or equal probability of developing CaCu compared to women of the same age, and with lower use of the test, coming from the highlands and considering it risky to undergo VIA.</p><p><strong>Conclusion: </strong>The VIA screening program for CaCu would not be achieving the desired impact. There is a need to strengthen strategies and interventions in primary care to improve screening behaviors and rates.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 3","pages":"526-533"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141440624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia that might affect 1/5000-10 000 individuals worldwide. It is a rare and underdiagnosed condition. Population-based epidemiological studies are crucial for comprehending and quantifying the impact of this disease. We aim to estimate the prevalence in a Prepaid Health Care System of Buenos Aires, Argentina.
Methods: A descriptive cross-sectional study was designed, which included all patients over 18 years of age affiliated with the Hospital Italiano Medical Care Program (IHMCP), a prepaid health maintenance organization (HMO) of Buenos Aires. For case inclusion, individuals were required to have a clinical diagnosis of HHT. Case detection included the search in our Institutional Registry. The prevalence was calculated by dividing the number of cases of HHT by the total number of all active affiliates at January 2023. Age and gender specific prevalence rates were estimated.
Results: 48 cases were reported. The prevalence was 3.2 in 10 000 (IC 95% 2.4-4.2). Specific prevalence in women was 3.9 in 10 000 (IC 95% 2.8-5.5) and in men 2.1 in 10 000 (IC 95% 1.2-3.6). The average age was 54.8 (19), 35 patients were women (72.9%) with an average age of 55 (19.9), and 55 (17.2) for men. The most common referrals were physicians (60.4%) followed by family history (18.7%). The 48 patients corresponded to 39 families.
Discussion: The prevalence identified in our study is higher than the one documented in other studies.
{"title":"Prevalence of hereditary hemorrhagic telangiectasia in a medical care program organization in Buenos Aires, Argentina.","authors":"Marcelo M Serra, Melina Papi, Candelaria Serrano","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia that might affect 1/5000-10 000 individuals worldwide. It is a rare and underdiagnosed condition. Population-based epidemiological studies are crucial for comprehending and quantifying the impact of this disease. We aim to estimate the prevalence in a Prepaid Health Care System of Buenos Aires, Argentina.</p><p><strong>Methods: </strong>A descriptive cross-sectional study was designed, which included all patients over 18 years of age affiliated with the Hospital Italiano Medical Care Program (IHMCP), a prepaid health maintenance organization (HMO) of Buenos Aires. For case inclusion, individuals were required to have a clinical diagnosis of HHT. Case detection included the search in our Institutional Registry. The prevalence was calculated by dividing the number of cases of HHT by the total number of all active affiliates at January 2023. Age and gender specific prevalence rates were estimated.</p><p><strong>Results: </strong>48 cases were reported. The prevalence was 3.2 in 10 000 (IC 95% 2.4-4.2). Specific prevalence in women was 3.9 in 10 000 (IC 95% 2.8-5.5) and in men 2.1 in 10 000 (IC 95% 1.2-3.6). The average age was 54.8 (19), 35 patients were women (72.9%) with an average age of 55 (19.9), and 55 (17.2) for men. The most common referrals were physicians (60.4%) followed by family history (18.7%). The 48 patients corresponded to 39 families.</p><p><strong>Discussion: </strong>The prevalence identified in our study is higher than the one documented in other studies.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 2","pages":"221-226"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mauricio A Gonzalez, Alejandro García Hevia, Pablo M Fernández, Aida V Canga, Jorge A Obeid
Enteral nutrition through jejunostomy is a common practice in any general surgery service; it carries a low risk of complications and morbidity and mortality. We present the case of a patient with an immediate history of subtotal gastrectomy that began nutrition through jejunostomy and complicated with intestinal necrosis due to non-occlusive ischemia in the short period. The purpose of this work is to report on this complication, its pathophysiology and risk factors to take it into account and be able to take appropriate therapeutic action early.
{"title":"[Necrosis and intestinal perforation associated with feeding by jejunostomy].","authors":"Mauricio A Gonzalez, Alejandro García Hevia, Pablo M Fernández, Aida V Canga, Jorge A Obeid","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Enteral nutrition through jejunostomy is a common practice in any general surgery service; it carries a low risk of complications and morbidity and mortality. We present the case of a patient with an immediate history of subtotal gastrectomy that began nutrition through jejunostomy and complicated with intestinal necrosis due to non-occlusive ischemia in the short period. The purpose of this work is to report on this complication, its pathophysiology and risk factors to take it into account and be able to take appropriate therapeutic action early.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 2","pages":"333-336"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana C Torre, Dolores P Bastard, Maria Diehl, Guillermo Rosa-Diez, Victoria Volonteri, Luis D Mazzuoccolo, Anahi L Belatti
Introduction: Calciphylaxis is a serious vascular disorder characterized by calcification of tunica media, intimal hyperplasia, thrombosis, and skin necrosis. It was described in patients with renal failure (UC), although it can occur in its absence (NUC). Its risk factors are under study and its diagnosis can be complex. Over a decade ago, its mortality was estimated at 60-80%. Recent studies indicate that it has decreased (40%).
Methods: A retrospective study was carried out in the period between January 1, 2011 and December 31, 2019. The past medical record, clinical characteristics, laboratory and histopathological findings, and evolution of all patients with calciphylaxis evaluated at the Hospital Italiano de Buenos Aires were reviewed.
Results: Thirty-nine patients were included. Sixtyone percent were men and 39% were NUC cases. Eightytwo percent had arterial hypertension, 66% obesity and 46% diabetes. Of those, 49% received coumarin anticoagulants. All patients with NUC and 75% with UC presented ulcers with necrosis, located more frequently on the legs. In 72% of the cases the histological diagnosis was made with one biopsy. In all the treatment was multimodal and mortality at one year was 42%.
Conclusion: We observed a high proportion of patients with NUC, in relation to what is reported in the literature, and that half received vitamin K antagonists. The histological diagnosis was made with one biopsy in most of the cases, as the surgical technique for taking the sample, the Von Kossa staining and the evaluation by an expert pathologist were the key of it.
{"title":"[Calciphylaxis, risk factors, treatment and outcomes. Retrospective study of 39 patients].","authors":"Ana C Torre, Dolores P Bastard, Maria Diehl, Guillermo Rosa-Diez, Victoria Volonteri, Luis D Mazzuoccolo, Anahi L Belatti","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Calciphylaxis is a serious vascular disorder characterized by calcification of tunica media, intimal hyperplasia, thrombosis, and skin necrosis. It was described in patients with renal failure (UC), although it can occur in its absence (NUC). Its risk factors are under study and its diagnosis can be complex. Over a decade ago, its mortality was estimated at 60-80%. Recent studies indicate that it has decreased (40%).</p><p><strong>Methods: </strong>A retrospective study was carried out in the period between January 1, 2011 and December 31, 2019. The past medical record, clinical characteristics, laboratory and histopathological findings, and evolution of all patients with calciphylaxis evaluated at the Hospital Italiano de Buenos Aires were reviewed.</p><p><strong>Results: </strong>Thirty-nine patients were included. Sixtyone percent were men and 39% were NUC cases. Eightytwo percent had arterial hypertension, 66% obesity and 46% diabetes. Of those, 49% received coumarin anticoagulants. All patients with NUC and 75% with UC presented ulcers with necrosis, located more frequently on the legs. In 72% of the cases the histological diagnosis was made with one biopsy. In all the treatment was multimodal and mortality at one year was 42%.</p><p><strong>Conclusion: </strong>We observed a high proportion of patients with NUC, in relation to what is reported in the literature, and that half received vitamin K antagonists. The histological diagnosis was made with one biopsy in most of the cases, as the surgical technique for taking the sample, the Von Kossa staining and the evaluation by an expert pathologist were the key of it.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 2","pages":"196-205"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140855446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Regarding CONICET, research, and science in Argentina: with pen and word].","authors":"Eduardo L De Vito","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 2","pages":"381-383"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pilar de Las Mercedes Pereyra, María de Los Ángeles Aciar, María Mercedes Fregenal, Gustavo A Ceballos, Luis A Ramírez Stieben
Primary hyperparathyroidism (PHPT) is characterized by elevated levels of calcium and parathyroid hormone (PTH). However, the interpretation of diagnostic tests, such as serum calcium and PTH levels, is complex in pregnant women. The aim of this report is to present a case of PHTP in a pregnant adolescent, with a special emphasis on an uncommon complication, as well as diagnostic and treatment strategies. A 17-year-old pregnant female presented with hyperemesis gravidarum and neurological symptoms, leading to the diagnosis of cerebral venous thrombosis. Further investigations revealed hypercalcemia and persistently elevated PTH levels, consistent with PHPT. After localization studies, the patient underwent an emergency parathyroidectomy with a diagnosis of parathyroid adenoma. During follow-up, intrauterine growth restriction and severe preeclampsia developed, necessitating an emergency cesarean section. Both the mother and neonate had favorable outcomes. PHPT is an infrequent condition in the pregnant population, and its diagnosis can be challenging due to the overlap of symptoms with normal physiological changes during pregnancy. The occurrence of uncommon complications, such as thrombotic phenomena, highlights the need for a comprehensive approach to ensure early detection and management. In most cases, parathyroidectomy is the treatment of choice.
{"title":"Primary hyperparathyroidism in pregnancy: a case report highlighting uncommon complication.","authors":"Pilar de Las Mercedes Pereyra, María de Los Ángeles Aciar, María Mercedes Fregenal, Gustavo A Ceballos, Luis A Ramírez Stieben","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Primary hyperparathyroidism (PHPT) is characterized by elevated levels of calcium and parathyroid hormone (PTH). However, the interpretation of diagnostic tests, such as serum calcium and PTH levels, is complex in pregnant women. The aim of this report is to present a case of PHTP in a pregnant adolescent, with a special emphasis on an uncommon complication, as well as diagnostic and treatment strategies. A 17-year-old pregnant female presented with hyperemesis gravidarum and neurological symptoms, leading to the diagnosis of cerebral venous thrombosis. Further investigations revealed hypercalcemia and persistently elevated PTH levels, consistent with PHPT. After localization studies, the patient underwent an emergency parathyroidectomy with a diagnosis of parathyroid adenoma. During follow-up, intrauterine growth restriction and severe preeclampsia developed, necessitating an emergency cesarean section. Both the mother and neonate had favorable outcomes. PHPT is an infrequent condition in the pregnant population, and its diagnosis can be challenging due to the overlap of symptoms with normal physiological changes during pregnancy. The occurrence of uncommon complications, such as thrombotic phenomena, highlights the need for a comprehensive approach to ensure early detection and management. In most cases, parathyroidectomy is the treatment of choice.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 2","pages":"342-346"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oscar Laudanno, Gabriel Ahumaran, Marcelo Thome, Paola Adami, Fernando Ustares, Oscar Bedini, Javier Bori, Gastón Ahualli, Pablo Rodríguez, Guillermo Fernández, Florencia Dulcich, Gladys Filo, Bianca Laudanno, Marina Khoury
Introduction: The optimal management of Helicobacter pylori (H pylori) infection remains unclear. Updated information concerning local data is needed to design the best strategy to treat H. pylori infection to reach high eradication rates. The Argentinean Registry (Hp-ArgReg) on H. pylori management was launched to monitor the eradication practices of gastroenterologists. The objective was to assess the effectiveness and safety of firstline H. pylori treatment in Argentina.
Materials and methods: A multicenter prospective registry of the clinical practice of the Argentinean gastroenterologists concerning H. pylori infection (Hp-ArgReg) was developed. Variables included: patient demographic information, previous eradication attempts, prescribed treatment, adverse events, compliance and outcome.
Results: Overall, 800 patients were included and 727 patients received first-line empirical treatment. The most frequent treatment indications were dyspepsia (78%) and gastroduodenal ulcer (12%). Among first-line treatments, quadruple therapies (with or without bismuth) achieved eradication rates of 94.9%, while triple therapies achieved eradication rates of 78.9%. Quadruple therapies were significantly more effective than triple therapies (P < 0.01, OR 5, CI 2.95-8.6). Sequential therapy with zinc showed an effectiveness of 95.6%. Adverse events were reported in 29% of the cases (mainly mild) and tolerance was quite similar among therapies.
Conclusion: in Argentina, Quadruple therapies with or without bismuth and sequential therapy with zinc showed an H. pylori eradication effectiveness of over 90% in real clinical practice. Local Registries for H pylori management could help to control the spread of antibiotic resistance.
{"title":"[Argentinean registry on the management of Helicobacter pylori infection: effectiveness and safety of first line treatment].","authors":"Oscar Laudanno, Gabriel Ahumaran, Marcelo Thome, Paola Adami, Fernando Ustares, Oscar Bedini, Javier Bori, Gastón Ahualli, Pablo Rodríguez, Guillermo Fernández, Florencia Dulcich, Gladys Filo, Bianca Laudanno, Marina Khoury","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The optimal management of Helicobacter pylori (H pylori) infection remains unclear. Updated information concerning local data is needed to design the best strategy to treat H. pylori infection to reach high eradication rates. The Argentinean Registry (Hp-ArgReg) on H. pylori management was launched to monitor the eradication practices of gastroenterologists. The objective was to assess the effectiveness and safety of firstline H. pylori treatment in Argentina.</p><p><strong>Materials and methods: </strong>A multicenter prospective registry of the clinical practice of the Argentinean gastroenterologists concerning H. pylori infection (Hp-ArgReg) was developed. Variables included: patient demographic information, previous eradication attempts, prescribed treatment, adverse events, compliance and outcome.</p><p><strong>Results: </strong>Overall, 800 patients were included and 727 patients received first-line empirical treatment. The most frequent treatment indications were dyspepsia (78%) and gastroduodenal ulcer (12%). Among first-line treatments, quadruple therapies (with or without bismuth) achieved eradication rates of 94.9%, while triple therapies achieved eradication rates of 78.9%. Quadruple therapies were significantly more effective than triple therapies (P < 0.01, OR 5, CI 2.95-8.6). Sequential therapy with zinc showed an effectiveness of 95.6%. Adverse events were reported in 29% of the cases (mainly mild) and tolerance was quite similar among therapies.</p><p><strong>Conclusion: </strong>in Argentina, Quadruple therapies with or without bismuth and sequential therapy with zinc showed an H. pylori eradication effectiveness of over 90% in real clinical practice. Local Registries for H pylori management could help to control the spread of antibiotic resistance.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"84 5","pages":"884-892"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}